Inroads to Predict in Vivo Toxicology—An Introduction to the eTOX Project
暂无分享,去创建一个
M. Cases | F. Sanz | K. Briggs | D. J. Heard | M. Pastor | F. Pognan | C. Schwab | T. Steger-Hartmann | A. Sutter | David K. Watson | J. Wichard
[1] W. Russell,et al. Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.
[2] U. Kodavanti,et al. Cationic amphiphilic drugs and phospholipid storage disorder. , 1990, Pharmacological reviews.
[3] W H Halliwell,et al. Cationic Amphiphilic Drug-Induced Phospholipidosis , 1997, Toxicologic pathology.
[4] U. Busch,et al. A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals , 1997, Microscopy research and technique.
[5] G. Gores,et al. Mechanisms of hepatotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Philip N. Judson,et al. Using Argumentation for Absolute Reasoning about the Potential Toxicity of Chemicals , 2003, J. Chem. Inf. Comput. Sci..
[7] Philip N. Judson,et al. Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of Xenobiotics , 2003, J. Chem. Inf. Comput. Sci..
[8] G. Cruciani,et al. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. , 2005, Journal of medicinal chemistry.
[9] B J Blaauboer,et al. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing. , 2005, Regulatory toxicology and pharmacology : RTP.
[10] Tudor I. Oprea,et al. Descriptor collision and confusion: Toward the design of descriptors to mask chemical structures , 2005, J. Comput. Aided Mol. Des..
[11] Alfonso Valencia,et al. Text-mining approaches in molecular biology and biomedicine. , 2005, Drug discovery today.
[12] David B. Searls,et al. Data integration: challenges for drug discovery , 2005, Nature Reviews Drug Discovery.
[13] Y-K Lee,et al. Validation of an in vitro screen for phospholipidosis using a high-content biology platform , 2006, Cell Biology and Toxicology.
[14] Iya Khalil,et al. Achieving confidence in mechanism for drug discovery and development. , 2007, Drug discovery today.
[15] J. Kramer,et al. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.
[16] R Daniel Benz,et al. Toxicological and clinical computational analysis and the US FDA/CDER , 2007, Expert opinion on drug metabolism & toxicology.
[17] U. Boelsterli,et al. Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity? , 2007, Toxicology and applied pharmacology.
[18] A. Bender,et al. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.
[19] Naomi L Kruhlak,et al. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models , 2008, Toxicology mechanisms and methods.
[20] Jules C Hancox,et al. The hERG potassium channel and hERG screening for drug-induced torsades de pointes. , 2008, Pharmacology & therapeutics.
[21] Balázs Sarkadi,et al. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.
[22] Carol A Marchant,et al. In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic , 2008, Toxicology mechanisms and methods.
[23] H. Federsel,et al. Handing over the baton: connecting medicinal chemistry with process R&D. , 2008, Drug news & perspectives.
[24] Chihae Yang,et al. Toxicity Data Informatics: Supporting a New Paradigm for Toxicity Prediction , 2008, Toxicology mechanisms and methods.
[25] C. Funk. The role of hepatic transporters in drug elimination. , 2008, Expert opinion on drug metabolism & toxicology.
[26] Alexander Tropsha,et al. Quantitative structure-activity relationship modeling of rat acute toxicity by oral exposure. , 2009, Chemical research in toxicology.
[27] Philip Judson,et al. Using In Silico Tools in a Weight of Evidence Approach to Aid Toxicological Assessment , 2010, Molecular informatics.
[28] Mark T. D. Cronin,et al. Recent Advances in QSAR Studies , 2010 .
[29] Paola Gramatica,et al. Oral LD50 toxicity modeling and prediction of per- and polyfluorinated chemicals on rat and mouse , 2011, Molecular Diversity.
[30] M. Bush,et al. Probabilistic Risk Analysis: Improving Early Drug Development Decision Making , 2010, Clinical pharmacology and therapeutics.
[31] Jordi Mestres,et al. Anticipating drug side effects by comparative pharmacology , 2010, Expert opinion on drug metabolism & toxicology.
[32] A. Bader,et al. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages , 2010, Expert opinion on drug metabolism & toxicology.
[33] Nigel Greene,et al. The computational prediction of genotoxicity , 2010, Expert opinion on drug metabolism & toxicology.
[34] Pantelis Sopasakis,et al. Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.
[35] M. Trauner,et al. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. , 2010, Pharmacology & therapeutics.
[36] Ovanes Mekenyan,et al. Use of genotoxicity information in the development of integrated testing strategies (ITS) for skin sensitization. , 2010, Chemical research in toxicology.
[37] Nigel Greene,et al. Developing structure-activity relationships for the prediction of hepatotoxicity. , 2010, Chemical research in toxicology.
[38] Ferran Sanz,et al. A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity , 2011, J. Chem. Inf. Model..
[39] Ivan Rusyn,et al. Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches. , 2011, Chemical research in toxicology.
[40] MedDRA , 2012, Pharmaceutical Medicine.